Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glucose Intolerance: later-stage trial registry
6 of 15 indexed Glucose Intolerance trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 6 currently recruiting · #1,140 of 28,707 conditions by registered trial count
Glucose Intolerance: 15 US clinical trials tracked, 6 recruiting.
Glucose Intolerance is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Signos, running 2 of these trials.
Enrollment posture brief
Registry condition glucose-intolerance
OPEN 6 | RECR 40% | LATE 1 | EARLY 0 | RANK #1140 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Glucose Intolerance lists 6 open slots (40% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Glucose Intolerance on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Glucose Intolerance is recruiting below its size-band peers.
6 of 15 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Glucose Intolerance trials is spread across many organizations.
Signos accounts for 2 of 15 trials (13.3%). 14 distinct sponsors appear on at least one study for this condition label.
-
Most Glucose Intolerance trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 15 trials that report a genuine target (sentinel values excluded). 10 of those (66.7%) plan for fewer than 100 participants.
-
Glucose Intolerance research is mostly interventional.
12 interventional and 3 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
Rare and Atypical Diabetes Network
University of South Florida
NCT05544266
The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults
Old Dominion University
NCT05468255
Time to Move in Pregnancy Hyperglycemia
The University of Tennessee, Knoxville
NCT06125704
The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU
Massachusetts General Hospital
NCT04737200
Sleep and Metabolism
Oregon Health and Science University
NCT05775627
The Acute T-Rex (Timing of Resistance Exercise) Study
University of Utah
NCT06366399
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
Signos
NCT05121844
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
Signos
NCT05874635
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
University of North Carolina, Chapel Hill
NCT00067587
Glucose Risk Assessment in Employer Populations
DexCom
NCT04529824
Almond Consumption and Glycemia
Purdue University
NCT03236116
A Trial of Tadalafil and Glycemic Traits
Thomas J. Wang, MD
NCT01444651
Physical Inactivity Impacts on Blood Vessel Health and Glucose Levels in an Aging Population
Leryn Reynolds
NCT04812392
Daily Vinegar Ingestion and 24-Hour Blood Glucose Control
Arizona State University
NCT06319443
Postpartum Weight Loss and Exercise (PRIDE)
Pennington Biomedical Research Center
NCT01296516
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Glucose Intolerance records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Glucose Intolerance trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Glucose Intolerance page
15 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Glucose Intolerance trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Signos sponsors the most Glucose Intolerance trials on record, review their full trial history before evaluating a specific study. See Signos's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Glucose Intolerance condition card totals 15 registered trials; most-linked intervention Continuous Glucose Monitor Device; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.